Baidu Provides Update on Voluntary Conversion to Dual-Primary Listing on the Main Board of the Hong Kong Stock Exchange
BEIJING, Aug. 27, 2026 /PRNewswire/ -- Baidu, Inc. ("Baidu" or the "Company") (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)), a leading AI company with strong Internet foundation, today announced that the Company's voluntary...
Hyundai Motor Company Charts Profit-Driven Growth Roadmap at 2026 CEO Investor Day
SEOUL, South Korea, Aug. 26, 2026 /PRNewswire/ -- Hyundai Motor Company today announced an aggressive product offensive at its 2026 CEO Investor Day, reinforcing the company's goal of 5.55 million units in global sales by 2030 while also bolstering...
GreenCore Solutions Corp. (GSC) Goes Live with AI Orderability (AIO) Agents for Commerce Marketplaces
AI Agents for CPG and Beauty & Personal Care brands on the SM-AMP-CPG standard, human in the loop on every order VANCOUVER, BC and SYDNEY, Aug. 26, 2026 /PRNewswire/ -- GreenCore Solutions Corp. ("GSC" or the "Company"), AI Agents that sell...
The Entertainment Industry's Biggest Names Back Stability AI in Latest Funding Round
Total funding reaches $232M under new leadership with investor group comprised of Electronic Arts, Sony Music Group, Universal Music Group, Warner Music Group, and more LOS ANGELES, Aug. 25, 2026 /PRNewswire/ -- Stability AI, the leader in...
Puerto Rico Governor Says Island 'Open for Business': NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 25, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market...
Haisco enters into Exclusive License Agreement with new US venture founded by Population Health Partners and ARCH Venture Partners
BEIJING, Aug. 25, 2026 /PRNewswire/ -- On August 25, Haisco Pharmaceutical Group Co., Ltd. ("Haisco") (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with Sentivera, a new US venture founded by Population...
Senhwa Completes Enrollment in Phase 1b CX-5461 Expansion Trial; CSR Expected in Q1 2027
TAIPEI, Aug. 25, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492) today announced that it has completed enrollment in its Phase 1b expansion trial evaluating pidnarulex (CX-5461) monotherapy in patients with advanced solid tumors harboring...
Antengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19 x CD3 TCE) in B Cell-related Autoimmune Diseases
SHANGHAI and HONG KONG, Aug. 25, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...
SCX.ai (ASX: SCX) Strategic Partnership With Global AI Leader DDN to Power Australia's Largest Sovereign AI Inferencing Cloud
Alliance to scale sovereign AI capacity as demand for Australian-based AI infrastructure grows SYDNEY, Aug. 25, 2026 /PRNewswire/ -- Australian sovereign AI infrastructure pioneer SCX.ai and global AI data intelligence leader DDN today announced a...
OnTime Posts 140.7% Revenue Surge to RMB 4.035 Billion, Gross Profit Tops RMB 500 Million in H1 2026
HONG KONG, GUANGZHOU and SHENZHEN, China, Aug. 22, 2026 /PRNewswire/ -- Chinese mobility technology and service provider OnTime (9680.HK) announced its first-half 2026 financial results on August 19, achieving record highs in revenue, gross profit...